PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.\', \'Molecular Medical Biochemistry Unit, Biological Chemistry and Engineering Course, Graduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo, Japan.\', \'Division of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan.\', \'International Collaboration Unit, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan.\', \'Global Virus Network, Baltimore, MD, USA.\', \'Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan. takaoka@igm.hokudai.ac.jp.\', \'Molecular Medical Biochemistry Unit, Biological Chemistry and Engineering Course, Graduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo, Japan. takaoka@igm.hokudai.ac.jp.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41590-021-00942-0
?:doi
?:hasPublicationType
?:journal
  • Nature immunology
is ?:pmid of
?:pmid
?:pmid
  • 33976430
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 14.007
?:rankingScore_hIndex
  • 336
is ?:relation_isRelatedTo_publication of
?:title
  • RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all